Dr. Michael Lapelusa, MD
- Part D claims, 2024
- 21
- Publications
- 18
- Hospital affiliations
- 1
- Industry payments
- $962
- Medical group
- 1
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lapelusa's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael Lapelusa is an internist in Houston, Texas
Dr. Lapelusa practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Lapelusa's NPI, 1831728401, was assigned on April 6, 2020. Dr. Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine in 2020. Dr. Lapelusa's Texas license number on file is V0455.
- NPI
- 1831728401NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6305261215
- NPI enumeration date
- April 6, 2020
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 2020
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael Lapelusa practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Lapelusa's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael Lapelusa is affiliated with 1 site of care and 1 medical group
Dr. Lapelusa's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.
Sources: Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael Lapelusa's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lapelusa practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael Lapelusa is one of 8,437 internists in Texas
Internal medicine is Dr. Lapelusa's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lapelusa is board certified in internal medicine by the American Board of Internal Medicine. Dr. Lapelusa has a license on file in Texas.
Specialties and state licenses
- Internal medicine, TexasPrimary
Internists near Dr. Lapelusa
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael Lapelusa's patients have a median age of 64
Across all payers, Dmand AI patient panel data puts Dr. Lapelusa's median patient age at 64, with 0% women.
Dr. Lapelusa's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 64
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. Michael Lapelusa wrote 21 Medicare Part D claims in 2024
In 2024, Dr. Lapelusa wrote 21 Medicare Part D claims for 12 patients. 95% of them were for generic drugs. They cover 7 drugs, with $2,772 in total drug cost. In 2022, CMS named 238 claims across 13 drugs.
Dr. Lapelusa's Part D claims by kind of drug, 2024
- Generic20 claims95%
- Brand-name and other1 claims5%
Dr. Lapelusa's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 2382023: 12547%
Drugs named by CMS: 7 in 2023, 13 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Michael Lapelusa takes part in Medicare
Dr. Lapelusa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael Lapelusa has 18 publications on record
Dmand AI links 18 papers to Dr. Lapelusa, published from 2021 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Colorectal Neoplasms, Biomarkers, Tumor and Circulating Tumor DNA. Dr. Lapelusa has published most often in Cancers (Basel). Dr. Lapelusa's most frequent co-authors are Ahmed O. Kaseb, MD, Sunyoung S. Lee, MD and Hesham M. Amin, MD.
Dr. Lapelusa's papers by year, 2021 to 2025
Topics Dr. Lapelusa writes about most
- Colorectal Neoplasms
- Biomarkers, Tumor
- Circulating Tumor DNA
- Neoadjuvant Therapy
Dr. Lapelusa's most frequent co-authors
- Ahmed O. Kaseb, MD6 shared papers
- Sunyoung S. Lee, MD5 shared papers
- Hesham M. Amin, MD4 shared papers
Recent publications by Dr. Lapelusa
J Immunother Precis Oncol
See who Dr. Lapelusa researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lapelusa works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael Lapelusa received $962 in industry payments from 2023 to 2025
CMS Open Payments shows 19 general payments to Dr. Lapelusa from 12 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $338.
General payments to Dr. Lapelusa by program year, 2023 to 2025
Companies that paid Dr. Lapelusa the most, 2023 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine
Dr. Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine in 2020.
- Medical school
- Board certified in internal medicine
Source: Dmand AI Professional Profile Data
Dr. Michael Lapelusa accepts plans from 3 insurance carriers
Dr. Lapelusa is in network with 3 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
- Elevance
- Aetna
- Blue Cross Blue Shield of Michigan
Plan types Dr. Lapelusa accepts, by number of carriers
- HMO3
- POS3
- PPO3
- EPO2
- Medicare1
Source: Dmand AI Insurance Network Data
Sources for Dr. Michael Lapelusa's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael Lapelusa
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael Lapelusa's NPI number?
Dr. Michael Lapelusa's NPI number is 1831728401. It was assigned on April 6, 2020, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael Lapelusa?
Dr. Michael Lapelusa is an internist in Houston, Texas. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Michael Lapelusa practice?
Dr. Lapelusa practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Lapelusa's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. Michael Lapelusa's medical license number?
Dr. Lapelusa's Texas license number on file is V0455.
Which hospitals is Dr. Michael Lapelusa affiliated with?
Dr. Lapelusa practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. Michael Lapelusa part of?
Dr. Lapelusa is linked to Physicians Referral Service.
Does Dr. Michael Lapelusa accept Medicare?
Yes. CMS lists Dr. Lapelusa as accepting Medicare assignment.
Is Dr. Michael Lapelusa board certified?
Yes. Dr. Lapelusa is board certified in internal medicine by the American Board of Internal Medicine.
Where did Dr. Michael Lapelusa go to medical school?
Dr. Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine in 2020.
What drugs does Dr. Michael Lapelusa prescribe most?
In 2023 Medicare Part D data, Dr. Lapelusa's most prescribed drugs by claims were Atorvastatin Calcium, Amlodipine Besylate and Fluticasone Propionate.
Show 5 more questionsShow fewer questions
Has Dr. Michael Lapelusa received payments from drug or device companies?
CMS Open Payments shows $962 in general payments to Dr. Lapelusa from 12 companies from 2023 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Michael Lapelusa been practicing?
Dr. Lapelusa graduated from medical school in 2020, 6 years ago.
Does Dr. Michael Lapelusa do research?
Dmand AI links 18 publications to Dr. Lapelusa, published from 2021 to 2025.
Who does Dr. Michael Lapelusa publish with?
Dr. Lapelusa's most frequent co-authors are Ahmed O. Kaseb, MD (6 shared papers), Sunyoung S. Lee, MD (5 shared papers) and Hesham M. Amin, MD (4 shared papers).
What insurance does Dr. Michael Lapelusa accept?
Dr. Lapelusa is in network with 3 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to internal medicine practices?
See internists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card